ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 142 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $21,457,000 | +8.9% | 1,358,056 | -12.5% | 0.81% | +2.4% |
| Q1 2018 | $19,709,000 | -0.5% | 1,551,873 | -10.3% | 0.79% | +3.5% |
| Q4 2017 | $19,809,000 | +2.4% | 1,730,028 | +9.6% | 0.76% | -3.0% |
| Q3 2017 | $19,336,000 | +41.5% | 1,578,477 | +32.2% | 0.79% | +37.8% |
| Q2 2017 | $13,668,000 | +9.2% | 1,193,672 | +98.3% | 0.57% | +11.1% |
| Q1 2017 | $12,518,000 | -1.9% | 601,832 | -1.9% | 0.51% | -5.5% |
| Q4 2016 | $12,755,000 | +116.3% | 613,232 | +159.6% | 0.54% | +91.5% |
| Q2 2016 | $5,898,000 | – | 236,193 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |